In patients with XLH, serum 1,25(OH)2D levels are inappropriately low for the prevailing serum phosphate levels, due to high FGF23 downregulating CYP27B1 and upregulating CYP24A1 [10]. The gene discussed is CYP24A1; the disease is X-linked hypophosphatemia.